Gayle Smink, MD, MPH - Penn State Cancer Institute
Researcher Profile
Gayle Smink, MD, MPH
Associate Professor, Department of Pediatrics
Disease Teams:
Cancer Institute, Pediatric Cancer Team
Research Interests
- Pediatrics
- Leukemia
- Therapeutics
- Sickle Cell Anemia
- Genes
- Neoplasms
- Newborn Infant
- Bone and Bones
- Child
- Femur
- Bone Density
- Education
Clinical Trials
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-RiskWNT-Driven Medulloblastoma Patients
Recent Publications
2024
Gay, K, Smink, G, Mulieri, K & Dandekar, S 2024, 'Delayed serum sickness reaction after initial hypersensitivity reaction to calaspargase during treatment for B-cell acute lymphoblastic leukemia', Pediatric Blood and Cancer, vol. 71, no. 5, e30922. https://doi.org/10.1002/pbc.30922
2021
McGrath, M & Smink, G 2021, 'Double and single mixed-lineage leukemia-rearranged subclones in pediatric acute myeloid leukemia: a case report', Journal of Medical Case Reports, vol. 15, no. 1, 228. https://doi.org/10.1186/s13256-021-02841-2
2020
Dhanyamraju, PK, Iyer, S, Smink, G, Bamme, Y, Bhadauria, P, Payne, JL, Dovat, E, Klink, M & Ding, Y 2020, 'Transcriptional regulation of genes by ikaros tumor suppressor in acute lymphoblastic leukemia', International journal of molecular sciences, vol. 21, no. 4, 1377. https://doi.org/10.3390/ijms21041377
Wang, J, Bin, Q, Cheng, B, Yan, L, Xiong, L, Tan, BH, McGrath, M, Smink, GM, Song, C & Tong, Y 2020, 'Two novel deleterious variants of Angiotensin-I-converting Enzyme gene identified in a family with recurrent anhydramnios', Molecular Genetics and Genomic Medicine, vol. 8, no. 6, e1239. https://doi.org/10.1002/mgg3.1239